Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs
Lexaria, a global innovator in drug delivery platforms, has announced its GLP-1 research plans for the 2024 calendar year The…
Lexaria, a global innovator in drug delivery platforms, has announced its GLP-1 research plans for the 2024 calendar year The…
The hoopla surrounding crypto offerings’ highs and lows has attracted scores of new investors in a sort of modern-day gold…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, is reporting that an expanded…
A coalition of military veterans’ organizations is joining a growing number of entities encouraging the U.S. DEA to reschedule cannabis…
Correlate Energy, a publicly traded distributed energy solutions company, is taking advantage of the expanding renewable energy landscape and is…
Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element…
Astrotech (NASDAQ: ASTC ), an instrumentation company focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM) that is now used…
PaxMedica (NASDAQ: PXMD) recently released an insightful video detailing the outcomes of its Phase 2 study on autism spectrum disorder…
Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a strategic metals enterprise, is focused on establishing North American independence in the…
FingerMotion (NASDAQ: FNGR), a mobile services and data company, has announced that it will be participating at the Microcap Conference; the…